ARCHIVES

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

This article is from The Cancer Letter archive.

Vol. 07 No. 01 | January 2, 1981

Download PDF Visit The Full Archive

Related Articles

Program Committee Lists 10 Papers At AACR Meeting

July 19, 1985

European Commission Approves Subcutaneous Rituximab

March 28, 2014

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991

Two Workshops To Look For New Research Areas

October 29, 1976

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Animas As Early Warning “Sentinels” Part Of DCE Study

July 31, 1987